PCM
CDNA icon

Perkins Capital Management’s CareDx CDNA Stock Holding History

Perkins Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-56,942
Closed -$969K – 103
2022
Q3 		$969K Sell
56,942
-1,550
-3% -$33.3K 1.08% 31
2022
Q2 		$1.26M Buy
58,492
+800
+1% +$22.2K 1.3% 27
2022
Q1 		$2.13M Hold
57,692
– – 1.75% 19
2021
Q4 		$2.62M Sell
57,692
-2,750
-5% -$144K 1.77% 16
2021
Q3 		$3.83M Sell
60,442
-42,200
-41% -$3.21M 2.37% 9
2021
Q2 		$9.39M Sell
102,642
-3,500
-3% -$278K 5.33% 1
2021
Q1 		$7.23M Sell
106,142
-1,650
-2% -$128K 4.18% 3
2020
Q4 		$7.81M Sell
107,792
-11,800
-10% -$684K 5.11% 3
2020
Q3 		$4.54M Buy
+119,592
New +$4.04M 4.17% 4
2020
Q1 		$2.68M Buy
122,633
+41,500
+51% +$930K 3.23% 6
2019
Q4 		$1.75M Sell
81,133
-29,200
-26% -$670K 1.57% 20
2019
Q3 		$2.5M Sell
110,333
-16,417
-13% -$455K 2.15% 11
2019
Q2 		$4.56M Sell
126,750
-5,150
-4% -$165K 3.19% 5
2019
Q1 		$4.16M Sell
131,900
-66,060
-33% -$1.92M 2.74% 7
2018
Q4 		$4.98M Sell
197,960
-13,100
-6% -$337K 3.86% 4
2018
Q3 		$6.09M Buy
211,060
+9,500
+5% +$178K 3.66% 3
2018
Q2 		$2.47M Buy
201,560
+79,210
+65% +$908K 1.77% 8
2018
Q1 		$975K Sell
122,350
-56,289
-32% -$347K 0.88% 38
2017
Q4 		$1.31M Buy
178,639
+40,089
+29% +$250K 1.26% 21
2017
Q3 		$513K Buy
+138,550
New +$291K 0.54% 58

Other funds holding CDNA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Perkins Capital Management's CDNA Position: Q4 2022 in Review

Perkins Capital Management sold out of CareDx (CDNA) in Q4 2022, closing a stake of 56,942 shares — an estimated $969K sold.

Perkins Capital Management first reported a position in CDNA in Q3 2017 and held it in 20 quarters. The position peaked at $9.39M in Q2 2021. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.

  • Perkins Capital Management reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
  • Perkins Capital Management sold 56,942 CareDx shares in Q4 2022, an estimated $969K.
  • Perkins Capital Management first reported a position in CareDx in Q3 2017 and held it in 20 quarters.
  • Perkins Capital Management's CareDx position peaked at $9.39M in Q2 2021.
  • 168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.

Based on Perkins Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.